Public Joint-Stock Company Pharmsynthez announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was RUB 349.388 million compared to RUB 718.541 million a year ago. Operating loss was RUB 540.651 million compared to RUB 481.006 million a year ago. Net loss was RUB 417.702 million compared to RUB 357.764 million a year ago. Basic loss per share from continuing operations was RUB 1.39 compared to RUB 1.3 a year ago.